EA200200545A1 - ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT - Google Patents

ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT

Info

Publication number
EA200200545A1
EA200200545A1 EA200200545A EA200200545A EA200200545A1 EA 200200545 A1 EA200200545 A1 EA 200200545A1 EA 200200545 A EA200200545 A EA 200200545A EA 200200545 A EA200200545 A EA 200200545A EA 200200545 A1 EA200200545 A1 EA 200200545A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb
Prior art date
Application number
EA200200545A
Other languages
Russian (ru)
Inventor
Джером Герберт Флейш
Роджер Стюарт Бенджамин
Джейсон Скотт Сойер
Беверли Энн Тейчер
Дуглас Вэйд Бэйт
Эдвард К. Р. Смит
Вилльям Томас Макмиллен
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200200545A1 publication Critical patent/EA200200545A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Антагонисты лейкотриена (LTB) повышают эффективность 2',2'-дифторнуклеозидного противоракового агента.Отчет о международном поиске был опубликован 2002.02.14.Leukotriene antagonists (LTB) increase the effectiveness of 2 ', 2'-difluoro-nucleoside anti-cancer agent. The international search report was published 2002.02.14.

EA200200545A 1999-11-11 2000-11-09 ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT EA200200545A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
EA200200545A1 true EA200200545A1 (en) 2002-12-26

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200545A EA200200545A1 (en) 1999-11-11 2000-11-09 ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT

Country Status (22)

Country Link
EP (1) EP1231938A2 (en)
JP (1) JP2003513916A (en)
KR (1) KR20020069512A (en)
CN (1) CN1390139A (en)
AR (1) AR032432A1 (en)
AU (1) AU778829B2 (en)
BR (1) BR0015490A (en)
CA (1) CA2391416A1 (en)
CZ (1) CZ20021551A3 (en)
EA (1) EA200200545A1 (en)
HK (1) HK1050132A1 (en)
HU (1) HUP0204449A3 (en)
IL (1) IL148579A0 (en)
MX (1) MXPA02004733A (en)
NO (1) NO20022245L (en)
NZ (1) NZ517667A (en)
PE (1) PE20010701A1 (en)
PL (1) PL355172A1 (en)
SK (1) SK6492002A3 (en)
TR (1) TR200201245T2 (en)
WO (1) WO2001034137A2 (en)
ZA (1) ZA200202822B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Combination therapy for cancer
NZ522387A (en) * 2000-05-09 2003-09-26 Univ Creighton Methods for inhibiting proliferation and inducing apoptosis in cancer cells
AU2001282717A1 (en) 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
ATE515494T1 (en) 2004-05-05 2011-07-15 High Point Pharmaceuticals Llc NEW COMPOUNDS, THEIR PRODUCTION AND USE
WO2005105726A1 (en) 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
CN1302782C (en) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 Jixitabing hydrochloride solution type injection agent
MX2007016374A (en) 2005-06-30 2008-03-05 Novo Nordisk As Phenoxy acetic acids as ppar delta activators.
CN103224477A (en) 2005-12-22 2013-07-31 高点制药有限责任公司 Phenoxy acetic acids as PPAR delta activators
JP2009529512A (en) 2006-03-09 2009-08-20 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー Novel compounds, methods for their production and use
WO2008044729A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivative
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US20150284380A1 (en) 2012-10-31 2015-10-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
CN103319466B (en) * 2013-07-04 2016-03-16 郑州大学 Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
CZ20021551A3 (en) 2003-02-12
HK1050132A1 (en) 2003-06-13
WO2001034137A3 (en) 2002-02-14
PL355172A1 (en) 2004-04-05
HUP0204449A2 (en) 2003-04-28
EP1231938A2 (en) 2002-08-21
HUP0204449A3 (en) 2006-02-28
BR0015490A (en) 2002-07-09
WO2001034137A2 (en) 2001-05-17
KR20020069512A (en) 2002-09-04
PE20010701A1 (en) 2001-07-07
AU1599001A (en) 2001-06-06
SK6492002A3 (en) 2003-09-11
CN1390139A (en) 2003-01-08
MXPA02004733A (en) 2002-08-30
AU778829B2 (en) 2004-12-23
TR200201245T2 (en) 2004-08-23
CA2391416A1 (en) 2001-05-17
ZA200202822B (en) 2003-09-23
AR032432A1 (en) 2003-11-12
NO20022245L (en) 2002-07-09
NO20022245D0 (en) 2002-05-10
JP2003513916A (en) 2003-04-15
NZ517667A (en) 2004-05-28
IL148579A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
EA200200545A1 (en) ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT
EA200200097A1 (en) IMIDAZOMIDASOLES AND TRIAZOLES AS ANTI-INFLAMMATORY AGENTS
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
PT1413582E (en) PYRROLOBENZODIAZEPINAS DIMERICAS
ATE263157T1 (en) NEMATICIDE TRIFLUORBUTENE
EA200101046A1 (en) INDIVIDUAL BIS-INDOL DERIVATIVES
FI902555A0 (en) DIARYLSTYRYLKINOLINDISYROR.
SE9901077D0 (en) Novel use
EA200400475A1 (en) SUBSTITUTED DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF MALIGNANT TUMOR
BR0014990A (en) Ranphthalazinone tetrahydrothiopyrane derivatives as pde4 inhibitors
SE9801494D0 (en) Novel use
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
ATE201204T1 (en) DERIVATIVES OF THIAZOLIDINE-4-CARBONIC ACID AS CYTOPROTECTIVE AGENTS
BR9902084A (en) Heterocycles.
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
EA200300727A1 (en) DERIVATIVES OF 2H-1-BENZOPIRANE, METHODS OF THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS
AR022321A1 (en) USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE
DK1204659T3 (en) Serotonergic benzofurans
TR199901017A2 (en) Insecticide composition.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
BR0017046A (en) Use of azoles to prevent skin cancer
PT1244614E (en) TRIPTASE INHIBITORS
NO20020914D0 (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
DE60000826T2 (en) 14.BETA., 17-ALPHA-HYDROXYMETHYLANDROSTAN DERIVATIVES AS ANDROGENES
BR0008791A (en) Anticonvulsant derivatives, useful in treating essential tremor